An efficacy trial of Omalizumab in patients with severe asthma and chronic rhinosinusitis complicated with eosinophilic otitis media
Latest Information Update: 28 Jun 2016
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma; Otitis media; Rhinosinusitis
- Focus Therapeutic Use
- 28 Jun 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society